Correlation Between Scpharmaceuticals and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Scpharmaceuticals and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and NeuroSense Therapeutics.
Diversification Opportunities for Scpharmaceuticals and NeuroSense Therapeutics
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Scpharmaceuticals and NeuroSense is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and NeuroSense Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 8.19 times less risky than NeuroSense Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 18.00 in NeuroSense Therapeutics Ltd on September 1, 2024 and sell it today you would earn a total of 6.00 from holding NeuroSense Therapeutics Ltd or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 71.43% |
| Values | Daily Returns |
Scpharmaceuticals vs. NeuroSense Therapeutics Ltd
Performance |
| Timeline |
| Scpharmaceuticals |
| NeuroSense Therapeutics |
Scpharmaceuticals and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and NeuroSense Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. Pasithea Therapeutics Corp | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |